Compare ITRM & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRM | ASLE |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 296.8M |
| IPO Year | 2018 | 2018 |
| Metric | ITRM | ASLE |
|---|---|---|
| Price | $0.04 | $6.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $9.00 | $7.00 |
| AVG Volume (30 Days) | ★ 882.9K | 290.8K |
| Earning Date | 05-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.43 | ★ 63.64 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $335,286,000.00 |
| Revenue This Year | N/A | $23.41 |
| Revenue Next Year | $947.65 | $6.80 |
| P/E Ratio | ★ N/A | $34.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.14 | $5.56 |
| 52 Week High | $1.42 | $9.08 |
| Indicator | ITRM | ASLE |
|---|---|---|
| Relative Strength Index (RSI) | 20.39 | 30.61 |
| Support Level | N/A | $6.05 |
| Resistance Level | $0.39 | $6.17 |
| Average True Range (ATR) | 0.02 | 0.15 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 6.76 | 12.35 |
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.